Dimension Therapeutics Inc Stock

Stocks

17-10-05	Harwood Feffer LLP : Announces Investigation of Dimension Therapeutics, Inc.	PR
17-10-03	Dimension (DMTX) Alert: Johnson Fistel Investigates Proposed Sale of Dimension Therapeutics, Inc.; Are Shareholders Getting a Fair Price?	PR
17-10-02	Dimension Board Determines that Ultragenyx’s Unsolicited Proposal to Acquire Dimension for $6.00 Per Share Constitutes a “Superior Proposal”	GL
17-09-19	Dimension Board of Directors Determines Proposal from Ultragenyx Pharmaceutical Inc. Could Reasonably Be Expected to Lead to a “Superior Proposal”	GL
17-09-18	Dimension Confirms Receipt of Unsolicited Proposal from Ultragenyx	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIMENSION THERAPEUTICS INC	-.--%	-0.42%	-	-	0
WUXI APPTEC CO., LTD.	-3.42%	+4.90%	+61.15%	+87.70%	55.98B
ARGENX SE	-0.91%	-2.67%	+51.47%	+69.88%	53.69B
INSMED INCORPORATED	-2.14%	-9.13%	+2.74%	+421.65%	23.29B
BIONTECH SE	-0.47%	-1.53%	-18.61%	-15.41%	23.15B
WUXI BIOLOGICS (CAYMAN) INC.	-5.95%	-2.58%	+30.67%	-9.47%	20.58B
GENMAB A/S	-2.46%	-1.15%	+30.02%	-31.24%	17.76B
PHARMAESSENTIA CORPORATION	-4.55%	-1.95%	+192.65%	+349.58%	16.09B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-6.91%	-5.83%	+26.53%	+644.30%	15.93B
EXELIXIS, INC.	+0.23%	-2.49%	+24.26%	+187.16%	14B
Average	-2.66%	-0.43%	+44.54%	+189.35%	26.72B
Weighted average by Cap.	-2.69%	-0.88%	+45.10%	+149.22%

Employees

Sector